KEY HIGHLIGHTS COVAXIN neutralises multiple variants of SARS-CoV-2 It effectively neutralises the double mutant strain as well Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries New Delhi: ICMR study shows that COVAXIN made by Bharat Biotech is effective against multiple variants of SARS-CoV-2 and effectively neutralizes the double mutant strain as well. ICMR NIV has de